4-((5-hydroxy-2-adamantyl)amino)-1H-pyrrolo(2,3-b)pyridine-5-carboxamide,
4-((trans-5-hydroxyadamantan-2-yl)amino)-1H-pyrrolo(2,3-b)pyridine-5-carboxamide,
ASP015K,
peficitinib,
Peficitinib,
ASP015K,
UNII-HPH1166CKX,
944118-01-8,
ASP-015K,
HPH1166CKX,
4-[[(1R,3S)-5-hydroxy-2-adamantyl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide,
4-[[(1S,3R)-5-oxidanyl-2-adamantyl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide,
Peficitinib [USAN:INN],
ASP 015K,
9T6,
Peficitinib (USAN/INN),
Peficitinb (ASP015K, JNJ-54781532),
GTPL8315,
SCHEMBL1154418,
SCHEMBL1154421,
SCHEMBL4447032,
SCHEMBL9990240,
SCHEMBL9990248,
CHEMBL3137308,
SCHEMBL17645135,
BCP18465,
BDBM50124208,
DB11708,
SB16834,
SC-17960,
ASP015K; JNJ-54781532,
D10653,
Peficitinib pound ASP015K JNJ-54781532 pound(c),
1H-Pyrrolo(2,3-b)pyridine-5-carboxamide, 4-((5-hydroxytricyclo(3.3.1.13,7)dec-2-yl)amino)-, stereoisomer,
4-(((1R,2r,3S,5s,7s)-5-hydroxyadamantan-2-yl)amino)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide,
4-(((1R,2s,3S,5s,7s)-5-hydroxyadamantan-2-yl)amino)-1H-pyrrolo(2,3-b)pyridine-5-carboxamide,
D06EIC,
JNJ-54781532,